The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127306941 12730694 1 I 20160826 20160910 20160910 EXP JP-MLMSERVICE-20160701-0340984-1 JP-ACCORD-043754 ACCORD SHIGA Y, KANAYA Y, KONO R, TAKESHIMA S, SHIMOE Y, KURIYAMA M. DEMENTIA WITH LEWY BODIES PRESENTING MARKED TONGUE PROTRUSION AND BITE DUE TO LINGUAL DYSTONIA: A CASE REPORT.CLINICAL NEUROLOGY. 2016; 56(6):418-423. 53.00 YR F Y 0.00000 20160910 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127306941 12730694 1 PS CARBIDOPA/LEVODOPA CARBIDOPALEVODOPA 1 Y 2147483647 600 MG
127306941 12730694 2 SS QUETIAPINE. QUETIAPINE 1 Y 202152 75 MG
127306941 12730694 3 SS ROPINIROLE/ROPINIROLE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE 1 EXTENDED-RELEASE TABLETS Y 0 6 MG TABLET
127306941 12730694 4 I OLANZAPINE. OLANZAPINE 1 5 - 10 MG Y 0
127306941 12730694 5 SS RISPERIDONE. RISPERIDONE 1 Y 0 2 MG
127306941 12730694 6 SS ROTIGOTINE ROTIGOTINE 1 Y 0
127306941 12730694 7 C CLONAZEPAM. CLONAZEPAM 1 0 1.5 MG
127306941 12730694 8 C BROTIZOLAM BROTIZOLAM 1 0 .25 MG
127306941 12730694 9 C BIPERIDEN BIPERIDEN 1 Y 0 6 MG
127306941 12730694 10 C TIAPRIDE TIAPRIDE 1 50-150 MG 0
127306941 12730694 11 C PEROSPIRONE PEROSPIRONE 1 8-16 MG 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127306941 12730694 1 Dementia with Lewy bodies
127306941 12730694 2 Product used for unknown indication
127306941 12730694 3 Dementia with Lewy bodies
127306941 12730694 4 Product used for unknown indication
127306941 12730694 5 Product used for unknown indication
127306941 12730694 6 Product used for unknown indication
127306941 12730694 9 Parkinson's disease

Outcome of event

Event ID CASEID OUTC COD
127306941 12730694 HO
127306941 12730694 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127306941 12730694 Altered state of consciousness
127306941 12730694 Condition aggravated
127306941 12730694 Drug hypersensitivity
127306941 12730694 Drug interaction
127306941 12730694 Dyskinesia
127306941 12730694 Irritability
127306941 12730694 Oromandibular dystonia
127306941 12730694 Restlessness
127306941 12730694 Sexual dysfunction
127306941 12730694 Tongue biting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127306941 12730694 1 201405 0
127306941 12730694 3 201411 0
127306941 12730694 4 2013 0
127306941 12730694 6 2014 0
127306941 12730694 9 2013 0
127306941 12730694 10 2013 0
127306941 12730694 11 2013 0